Skip to main content

Video visit appointments available 7 days a week from 9:00am to 11:00pm. Learn More >>

COVID-19 Updates: Get the latest on vaccine information, in-person appointments, video visits and more. Learn More >>

Location

Texas Medical Center

Specialty
Cancer
Phone: 832-824-4661
Fax: 832-825-7374

Address

6621 FanninSuite 1630.14
Suite 1630.14
Houston, TX 77030

Robert A. Krance, MD

Professor, Department of Pediatrics, Section of Hematology-Oncology, Cell and Gene Therapy, Baylor College of Medicine

Education

School Education Degree Year
St. Jude Children's Research Hospital Fellowship Hematology-Oncology 1977
St. Jude Children's Research Hospital Residency Pediatrics 1975
Rocky Mountain College Residency Pediatrics 1972
Rush University Medical Center Residency Pediatrics 1972
Rocky Mountain College Internship Pediatrics 1971
Rush University Medical Center Internship Pediatrics 1971
Loyola University of Chicago Medical School Doctor of Medicine 1970

About

Dr. Robert Krance is the Director of the Pediatric Bone Marrow Transplant (BMT)/Stem Cell Transplant Program at Texas Children’s Hospital. The clinical program, one of the most active in the country, treats patients with various hematologic, oncologic, immunologic and genetic disorders.

Dr. Krance coordinates the clinical activities of the cell and gene therapy and the pediatric bone marrow transplant programs. 

His clinical interests include bone marrow transplantation and cell and gene therapy.

Board Certifications American Board of Pediatrics - Pediatric Medicine American Board of Pediatrics - Hematology/Oncology

Organizations

Organization Name Role
American Academy of Pediatrics (AAP) Member
American Society for Transplantation and Cellular Therapy (ASTCT) Member
American Society of Clinical Oncology (ASCO) Member
American Society of Hematology (ASH) Member

Research Statement

Dr. Robert Krance's research interests include: 1) the development of transplantation using alternative donors, 2) transplantation using less than fully HLA matched related donors, and 3) the impact of viral infection post-transplantation.

Current initiatives focus on the development of transplantation using alternative donors and less than fully HLA matched related donors. Investigations are under way into the use of antibodies directed against hematopoietic cells and methods of stem cell purification. In collaboration with other investigators in the Center for Cell and Gene Therapy (CAGT), new cell-based approaches are being conducted hopefully to diminish the impact of viral infection post transplantation.

Language

English

* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.